- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 24, 2025 | 104.41M sh |
| Long Term Debt | Q3 2025 · Jan 31, 2025 | $569.45M |
| Long Term Debt | Q3 2025 · Apr 30, 2024 | $568.61M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $584.01M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $540.4M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $837.03M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $871.09M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $1.47B |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $1.5B |
| Current Assets | Q3 2025 · Jan 31, 2025 | $1.69B |
| Current Assets | Q3 2025 · Apr 30, 2024 | $1.53B |
| Total Assets | Q3 2025 · Jan 31, 2025 | $2.33B |
| Total Assets | Q3 2025 · Apr 30, 2024 | $2.24B |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 104.5M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 103.15M sh |
| Capex | Q3 2025 · Jan 31, 2024 | $2.61M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $87.81M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $707.84M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $455.14M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $398.9M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $1.69 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $1.00 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $1.76 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $1.04 |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $40.9M |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $117.53M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $87.2M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $248M |
| Net Income | Q3 2025 · Jan 31, 2024 | $176.12M |
| Net Income | Q3 2025 · Jan 31, 2024 | $102.82M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$26.4M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$84.19M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $243.32M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $690.11M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $84.64M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $242.21M |
| Revenue | Q3 2025 · Jan 31, 2024 | $327.96M |
| Revenue | Q3 2025 · Jan 31, 2024 | $932.32M |